Magenta Therapeutics, Inc.·4

Sep 16, 7:40 PM ET

GARDNER JASON 4

4 · Magenta Therapeutics, Inc. · Filed Sep 16, 2021

Insider Transaction Report

Form 4
Period: 2021-09-14
GARDNER JASON
DirectorSee Remarks
Transactions
  • Award

    Common Stock

    2021-09-14+50,000301,212 total
Holdings
  • Common Stock

    (indirect: By Trust)
    292,990
  • Common Stock

    (indirect: By Trust)
    359,092
Footnotes (1)
  • [F1]On February 11, 2021, the reporting person was granted 100,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 50,000 restricted stock units and the corresponding issuance of 50,000 shares of issuer common stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION